Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Ritsuko, Seki"'
Autor:
Koichi, Osaki, Yoko, Sogabe, Ritsuko, Seki, Takayuki, Nakamura, Satoshi, Morishige, Eijiro, Oku, Yuka, Takata, Fumihiko, Mouri, Koji, Yoshimoto, Koji, Nagafuji, Takashi, Okamura
Publikováno v:
The Kurume medical journal. 67(2.3)
We investigated the molecular basis of factor VII (FVII) deficiency in a Japanese patient and identified compound heterozygous mutations. Factor VII activity and antigen levels in the patient were less than 5.0% and 6.5% of controls, respectively. Al
Autor:
KOICHI OSAKI, YOKO SOGABE, RITSUKO SEKI, TAKAYUKI NAKAMURA, SATOSHI MORISHIGE, EIJIRO OKU, YUKA TAKATA, FUMIHIKO MOURI, KOJI YOSHIMOTO, KOJI NAGAFUJI, TAKASHI OKAMURA
Publikováno v:
The Kurume Medical Journal. 67:83-89
Autor:
Kazutoshi Aoyama, Ritsuko Seki, Kensuke Sasaki, Yoshitaka Yamasaki, Takahiro Maeda, Takayuki Nakamura, Shuki Oya, Hidetoshi Ozawa, Yuichiro Semba, Koji Nagafuji, Fumihiko Mouri, Koichi Osaki, Toshihiro Miyamoto, Satoshi Morishige
Publikováno v:
International Journal of Hematology. 113:285-289
BCR-ABL1-like acute lymphoblastic leukemia (ALL) is a neoplasm of lymphoblasts committed to the B-cell lineage that lack the BCR-ABL1 translocation but show a pattern of gene expression very similar to that seen in ALL with BCR-ABL1 with poor prognos
Autor:
Fumihiko Mouri, Koichi Osaki, Koji Nagafuji, Ritsuko Seki, Kenji Kuboyama, Takayuki Nakamura, Shuki Oya, Kazutoshi Aoyama, Shinichi Mizuno, Maki Yamaguchi, Takashi Okamura, Hidetoshi Ozawa, Yoshitaka Yamasaki, Satoshi Morishige
Publikováno v:
Haemophilia. 26:826-833
Background Factor V (FV) deficiency is a monogenic inherited coagulation disorder considered to be an ideal indication for gene therapy. To investigate the possibility of therapeutic application of genome editing, we generated induced pluripotent ste
Autor:
Ahmad Mazahery, Koichi Osaki, Hidetoshi Ozawa, Shinichi Mizuno, Takayuki Nakamura, Fumihiko Mouri, Koji Nagafuji, Satoshi Morishige, Ritsuko Seki, Ken Ichi Yamamura, Takashi Okamura, Kei Nomura
Publikováno v:
International Journal of Hematology. 111:225-233
The clustered regulatory interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system is an efficient genome-editing tool that holds potential for gene therapy. Here, we report an application of this system for gene repair in hemophi
Autor:
Ritsuko Seki, Koichi Osaki, Shuki Oya, Takayuki Nakamura, Fumiko Arakawa, Hiroshi Saruta, Marina Nishi, Maki Yamaguchi, Satoshi Morishige, Koichi Ohshima, Kazutoshi Aoyama, Yoshitaka Yamasaki, Fumihiko Mouri, Koji Nagafuji
Publikováno v:
International Journal of Hematology. 110:506-511
Allogeneic hematopoietic cell transplantation (allo-HSCT) is considered the curative treatment option in patients with aggressive adult T cell leukemia/lymphoma (ATLL), but the treatment of relapse after allo-HSCT remains a major challenge. We report
Publikováno v:
Case Reports in Hematology, Vol 2014 (2014)
In the past decade, the serum free light chain (FLC) immunoassays have become widely available enabling greater sensitivity in the diagnosis and management of monoclonal light chain diseases. Here, we describe a rare case of serum free light chain on
Externí odkaz:
https://doaj.org/article/c5d3e36ab509403c892e536ca5e9d04c
Autor:
Fumihiko, Mouri, Yoshitaka, Yamasaki, Shuki, Ohya, Takayuki, Nakamura, Satoshi, Morishige, Maki, Yamaguchi, Kazutoshi, Aoyama, Ritsuko, Seki, Koichi, Osaki, Koji, Nagafuji
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(1)
Dose-adjusted (DA)-EPOCH-R causes profound neutropenia requiring relatively long hospital stays with multiple doses of granulocyte colony-stimulating factor (G-CSF). A single-dose pegylated G-CSF (PEG-G-CSF) has been used for the treatment of chemoth
Autor:
Shuki, Oya, Yoshitaka, Yamasaki, Takayuki, Nakamura, Satoshi, Morishige, Maki, Yamaguchi, Kazutoshi, Aoyama, Ritsuko, Seki, Humihiko, Mouri, Koichi, Osaki, Yoshiki, Naito, Koichi, Oshima, Koji, Nagafuji
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 61(11)
Multicentric Castleman disease (MCD) comprises a heterogeneous group of lymphoproliferative disorders. Interleukin 6 (IL-6) plays an important role in the MCD pathophysiology. Here, we report the case of a 17-year-old Japanese man who presented with
Autor:
Shuki Ohya, Koichi Osaki, Koji Nagafuji, Atsushi Nonami, Fumihiko Mouri, Maki Yamaguchi, Satoshi Morishige, Ritsuko Seki, Takayuki Nakamura, Yoshitaka Yamasaki
Publikováno v:
Nihon Naika Gakkai Zasshi. 107:2154-2161